Skip to search formSkip to main contentSkip to account menu

orpanoxin

Known as: 5-(4-chlorophenyl)-beta-hydroxy-2-furanpropanoic acid 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

F-776

Broader (1)

Propionates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Gastric Toxicity and Prostaglandin Content in Rats Dosed with Two Chemically Similar, Nonsteroidal Anti-Inflammatory Agents
Abstract Two chemically similar nonsteroidal anti-inflammatory drugs, orpanoxin and F-1067, had almost identical potencies and… 
1988
1988
EFFECTS OF ORPANOXIN ON ARACHIDONIC ACID METABOLISM OF HUMAN POLYMORPHONUCLEAR LEUCOCYTES AND PLATELETS IN VITRO
1. The effect of orpanoxin, a nonsteroidal anti‐inflammatory drug, on cyclooxygenase and lipoxygenase activity in human… 
1988
1988
Characterization of 5-[5-(4-chlorophenyl-2-furanyl)]dihydro-2(3H)-furanone as a nonsteroidal antiinflammatory drug.
5-[5-(4-Chlorophenyl-2-furanyl)]dihydro-2(3H)-furanone (F-1044), a nonsteroidal antiinflammatory drug related to orpanoxin, lacks… 
1985
1985
Anti-inflammatory activity of orpanoxin administered orally and topically to rodents
Orpanoxin, a nonsteroidal anti-inflammatory drug (NSAID) lacking gastric ulcerogenic effects in the therapeutic dose range in… 
1985
1985
Relative toxicities of several nonsteroidal antiinflammatory compounds in primary cultures of rat hepatocytes.
Primary cultures of intact, functional heptocytes were used to compare the relative toxicity of four nonsteroid antiinflammatory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)